These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 21163551)

  • 1. Gray matter atrophy rate as a marker of disease progression in AD.
    Anderson VM; Schott JM; Bartlett JW; Leung KK; Miller DH; Fox NC
    Neurobiol Aging; 2012 Jul; 33(7):1194-202. PubMed ID: 21163551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain atrophy progression measured from registered serial MRI: validation and application to Alzheimer's disease.
    Fox NC; Freeborough PA
    J Magn Reson Imaging; 1997; 7(6):1069-75. PubMed ID: 9400851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measuring atrophy in Alzheimer disease: a serial MRI study over 6 and 12 months.
    Schott JM; Price SL; Frost C; Whitwell JL; Rossor MN; Fox NC
    Neurology; 2005 Jul; 65(1):119-24. PubMed ID: 16009896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets.
    Falcon C; Tucholka A; Monté-Rubio GC; Cacciaglia R; Operto G; Rami L; Gispert JD; Molinuevo JL;
    Neuroimage Clin; 2018; 19():190-201. PubMed ID: 30023169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Following the Spreading of Brain Structural Changes in Alzheimer's Disease: A Longitudinal, Multimodal MRI Study.
    Weiler M; Agosta F; Canu E; Copetti M; Magnani G; Marcone A; Pagani E; Balthazar ML; Comi G; Falini A; Filippi M
    J Alzheimers Dis; 2015; 47(4):995-1007. PubMed ID: 26401778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combining short interval MRI in Alzheimer's disease: Implications for therapeutic trials.
    Schott JM; Frost C; Whitwell JL; Macmanus DG; Boyes RG; Rossor MN; Fox NC
    J Neurol; 2006 Sep; 253(9):1147-53. PubMed ID: 16998650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebral atrophy measurement in clinically isolated syndromes and relapsing remitting multiple sclerosis: a comparison of registration-based methods.
    Anderson VM; Fernando KT; Davies GR; Rashid W; Frost C; Fox NC; Miller DH
    J Neuroimaging; 2007 Jan; 17(1):61-8. PubMed ID: 17238871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rates of cerebral atrophy differ in different degenerative pathologies.
    Whitwell JL; Jack CR; Parisi JE; Knopman DS; Boeve BF; Petersen RC; Ferman TJ; Dickson DW; Josephs KA
    Brain; 2007 Apr; 130(Pt 4):1148-58. PubMed ID: 17347250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Robust atrophy rate measurement in Alzheimer's disease using multi-site serial MRI: tissue-specific intensity normalization and parameter selection.
    Leung KK; Clarkson MJ; Bartlett JW; Clegg S; Jack CR; Weiner MW; Fox NC; Ourselin S;
    Neuroimage; 2010 Apr; 50(2):516-23. PubMed ID: 20034579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positron emission tomography metabolic data corrected for cortical atrophy using magnetic resonance imaging.
    Labbé C; Froment JC; Kennedy A; Ashburner J; Cinotti L
    Alzheimer Dis Assoc Disord; 1996; 10(3):141-70. PubMed ID: 8876777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Focal atrophy in dementia with Lewy bodies on MRI: a distinct pattern from Alzheimer's disease.
    Whitwell JL; Weigand SD; Shiung MM; Boeve BF; Ferman TJ; Smith GE; Knopman DS; Petersen RC; Benarroch EE; Josephs KA; Jack CR
    Brain; 2007 Mar; 130(Pt 3):708-19. PubMed ID: 17267521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accuracy assessment of global and local atrophy measurement techniques with realistic simulated longitudinal Alzheimer's disease images.
    Camara O; Schnabel JA; Ridgway GR; Crum WR; Douiri A; Scahill RI; Hill DL; Fox NC
    Neuroimage; 2008 Aug; 42(2):696-709. PubMed ID: 18571436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneity of Regional Brain Atrophy Patterns Associated with Distinct Progression Rates in Alzheimer's Disease.
    Byun MS; Kim SE; Park J; Yi D; Choe YM; Sohn BK; Choi HJ; Baek H; Han JY; Woo JI; Lee DY;
    PLoS One; 2015; 10(11):e0142756. PubMed ID: 26618360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of methods for the automated calculation of volumes and atrophy rates in the hippocampus.
    Barnes J; Foster J; Boyes RG; Pepple T; Moore EK; Schott JM; Frost C; Scahill RI; Fox NC
    Neuroimage; 2008 May; 40(4):1655-71. PubMed ID: 18353687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased cortical curvature reflects white matter atrophy in individual patients with early multiple sclerosis.
    Deppe M; Marinell J; Krämer J; Duning T; Ruck T; Simon OJ; Zipp F; Wiendl H; Meuth SG
    Neuroimage Clin; 2014; 6():475-87. PubMed ID: 25610761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of Grey Matter Atrophy at Different Stages of Parkinson's and Alzheimer's Diseases and Relation to Cognition.
    Kunst J; Marecek R; Klobusiakova P; Balazova Z; Anderkova L; Nemcova-Elfmarkova N; Rektorova I
    Brain Topogr; 2019 Jan; 32(1):142-160. PubMed ID: 30206799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atrophy outcomes in multicentre clinical trials on Alzheimer's disease: effect of different processing and analysis approaches on sample sizes.
    Teipel SJ; Peters O; Heuser I; Jessen F; Maier W; Froelich L; Arlt S; Hüll M; Gertz HJ; Kornhuber J; Wiltfang J; Thome J; Rienhoff O; Meindl T; Hampel H; Grothe M
    World J Biol Psychiatry; 2011 Sep; 12 Suppl 1():109-13. PubMed ID: 21906007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Jacobian integration method increases the statistical power to measure gray matter atrophy in multiple sclerosis.
    Nakamura K; Guizard N; Fonov VS; Narayanan S; Collins DL; Arnold DL
    Neuroimage Clin; 2014; 4():10-7. PubMed ID: 24266007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using serial registered brain magnetic resonance imaging to measure disease progression in Alzheimer disease: power calculations and estimates of sample size to detect treatment effects.
    Fox NC; Cousens S; Scahill R; Harvey RJ; Rossor MN
    Arch Neurol; 2000 Mar; 57(3):339-44. PubMed ID: 10714659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebral atrophy measurements using Jacobian integration: comparison with the boundary shift integral.
    Boyes RG; Rueckert D; Aljabar P; Whitwell J; Schott JM; Hill DL; Fox NC
    Neuroimage; 2006 Aug; 32(1):159-69. PubMed ID: 16675272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.